Nezulcitinib for delivery by nebulized oral inhalation
US-2025288561-A1 · Sep 18, 2025 · US
Theravance Biopharma R&D Ip Llc patents
Theravance Biopharma R&D Ip Llc holds 414 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 414 |
| Recent patents | 49 |
| First publication | Dec 1, 2015 |
| Latest publication | Sep 18, 2025 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Dimethyl amino azetidine amides as JAK inhibitors
US-12398135-B2 · Aug 26, 2025 · US
Imidazolo indazole compounds as JAK inhibitors
US-12384761-B2 · Aug 12, 2025 · US
3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitor
US-12358931-B2 · Jul 15, 2025 · US
Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
US-12351561-B2 · Jul 8, 2025 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Nezulcitinib for delivery by nebulized oral inhalation
US-2025288561-A1 · Sep 18, 2025 · US
Dimethyl amino azetidine amides as JAK inhibitors
US-12398135-B2 · Aug 26, 2025 · US
Imidazolo indazole compounds as JAK inhibitors
US-12384761-B2 · Aug 12, 2025 · US
3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitor
US-12358931-B2 · Jul 15, 2025 · US
Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
US-12351561-B2 · Jul 8, 2025 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 404 |
| Chemistry & Metallurgy | 384 |
| Physics | 10 |
| Cross-Sectional Technologies | 7 |
| Operations & Transport | 2 |
Frequently asked questions
Answers are generated from the same data shown on this page.
- How many patents does Theravance Biopharma R&D Ip Llc have in patentsdb?
- Theravance Biopharma R&D Ip Llc is linked to 414 publications as assignee in our database.
- What technology areas does Theravance Biopharma R&D Ip Llc patent most?
- Top mapped technology areas by patent count: Human Necessities (404); Chemistry & Metallurgy (384); Physics (10).
- Is Theravance Biopharma R&D Ip Llc's patent activity growing?
- In our data, assignee counts were 13 in 2024 and 11 in 2025 (lower year over year).
- What are recent patents assigned to Theravance Biopharma R&D Ip Llc?
- See the “Recent patents” section above for the latest 5 publications we attribute to this assignee.